01 5Azathioprine
02 4Budesonid
03 19Budesonide
04 35Mesalazine
05 1Rifamycin Sodium
06 4Ursodeoxycholic Acid
07 3Ursodeoxycholic acid
01 3Capsule
02 2Dispersible Tablet
03 2Enema
04 1Enteric Granules
05 1Enteric-Coated Capsules
06 4Enteric-Coated Granules
07 1Enterogranules
08 4Extended Release Granule
09 10Film Coated Tablet
10 1Gastro-Resistant Capsule
11 2Gastro-Resistant Granule
12 1Gastro-Resistant Tablet
13 6Granules
14 1Hard Capsule
15 1Modified Release Tablet
16 1Oral Suspension
17 4Orodispersible Tablet
18 7Rectal Foam
19 1Rectal Liquid
20 1Rectal Suspension
21 10Suppository
22 1Suspension
23 6Tablet
01 10.5MG
02 40.5mg
03 11.5G
04 31.5g
05 11000MG
06 41000mg
07 1100MG
08 1100mg
09 31G
10 11MG
11 41g
12 11g/dose
13 31mg
14 1200MG
15 2250MG
16 4250mg
17 1250mg/5ml
18 12MG
19 12g
20 12mg
21 13000mg
22 13G
23 13MG
24 13g
25 23mg
26 14G
27 14MG
28 14g
29 14g/60ml
30 24mg
31 3500MG
32 6500mg
33 150mg
34 150mg/ml
35 175MG
36 175mg
37 19MG
38 29mg
39 4Blank
01 12Denmark
02 2Estonia
03 4Malta
04 11Norway
05 17Spain
06 25Switzerland
01 3Azafalk
02 3Budenofalcon
03 3Budenofalk
04 1Budenofalk Uno
05 1Budenofalk capsules
06 1Budenofalk suppositories
07 2Immufalk
08 3Intestifalk
09 1Intestifalk Uno
10 10Jorveza
11 1Relafalk
12 35Salofalk
13 6Ursofalk
14 1Ursofalk film-coated tablets
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 75mg
Packaging :
Brand Name : Azafalk
Approval Date : 17/09/2014
Application Number : 63011
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg
Packaging :
Brand Name : Azafalk
Approval Date : 17/09/2014
Application Number : 63011
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 50mg
Packaging :
Brand Name : Azafalk
Approval Date : 17/09/2014
Application Number : 63011
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Marketed
Registration Country : Norway
Dosage Form : Enterogranules
Dosage Strength :
Packaging :
Brand Name : Budenofalk
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Dosage Form : Suppository
Dosage Strength : 4mg
Packaging :
Brand Name : Budenofalk
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Dosage Form : Tablet
Dosage Strength : 0.5mg
Packaging :
Brand Name : Jorveza
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Dosage Form : Tablet
Dosage Strength : 1mg
Packaging :
Brand Name : Jorveza
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Dosage Form : Orodispersible Tablet
Dosage Strength : 1mg
Packaging :
Brand Name : Jorveza
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Brand Name : Immufalk
Approval Date : 08-03-2017
Application Number : 78165
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Brand Name : Immufalk
Approval Date : 08-03-2017
Application Number : 78164
Regulatory Info : Authorized
Registration Country : Spain
